Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595503 · ClinicalTrials.gov registry record · NA
Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01595503 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 5 participants.
The verdict
NCT01595503, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Repetitive transcranial magnetic stimulation (rTMS) is a new noninvasive therapy that uses magnetic energy applied to the scalp to modulate activity in the underlying regions of the brain. In this study we will examine the efficacy of treating auditory hallucinations in schizophrenia with rTMS, comparing two methods to target stimulation to a language processing region of the brain. One method targets the stimulation site using scalp landmarks, while the other uses functional magnetic resonance imaging (fMRI) combined with a language task.
Interventions
- PROCEDURE rTMS with fMRI-based targeting
- PROCEDURE rTMS with landmark-based targeting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01595503
The ClinicalTrials.gov registry entry for NCT01595503 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which rTMS with fMRI-based targeting is the first listed.
NCT01595503 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01595503 about?
NCT01595503 is a clinical study titled "Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia". Repetitive transcranial magnetic stimulation (rTMS) is a new noninvasive therapy that uses magnetic energy applied to the scalp to modulate activity in the underlying regions of the brain. In this study we will examine the efficacy of treating auditory hallucinations in schizophrenia with rTMS, comp...
What is the current status of trial NCT01595503?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2011-05. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01595503?
The interventions under investigation include: rTMS with fMRI-based targeting (PROCEDURE), rTMS with landmark-based targeting (PROCEDURE).
Who is sponsoring clinical trial NCT01595503?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.